News Daily News Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators Michael O'Riordan January 22, 2026
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Conference News ACC 2025 Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection Michael O'Riordan March 30, 2025
News Daily News Early Actions by Trump Administration Sow Uncertainty for CV Research Todd Neale January 30, 2025
News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back Todd Neale December 19, 2024
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023
News Conference News TCT 2022 FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years L.A. McKeown September 20, 2022
News Daily News COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK Michael O'Riordan September 15, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022
News Features Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay? Todd Neale December 09, 2021
News Conference News TCT 2021 Debating ISCHEMIA: Do the Results Apply to CABG, Too? Michael O'Riordan November 10, 2021
News Conference News ACC 2021 Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC Michael O'Riordan May 17, 2021
News Daily News Hydroxychloroquine Fails to Prevent COVID-19 in Those Exposed to the Virus: RCT Caitlin E. Cox June 05, 2020
News Features Mixed Messages on COVID-19 Masks: Science Falls Short As Deaths Mount Shelley Wood March 27, 2020
News Daily News Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL Michael O'Riordan January 17, 2020
News Conference News TCT 2018 CorMicA Offers Glimmer of Hope for Testing, Treating Angina Without Obstructive CAD Shelley Wood September 26, 2018
News Conference News TCT 2018 Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials Michael O'Riordan September 25, 2018
News Conference News ACC 2018 Bad BVS News: Analysis Points to Fast Reaction by Interventionalists to Absorb Safety Issues Michael O'Riordan March 11, 2018
News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017